121 related articles for article (PubMed ID: 37926573)
21. Identification of key genes and pathways in Ewing's sarcoma patients associated with metastasis and poor prognosis.
Li G; Zhang P; Zhang W; Lei Z; He J; Meng J; Di T; Yan W
Onco Targets Ther; 2019; 12():4153-4165. PubMed ID: 31213834
[No Abstract] [Full Text] [Related]
22. Combined analysis of gene expression and genome binding profiles identified potential therapeutic targets of ciclopirox in Ewing sarcoma.
Yuan B; Ji W; Xia H; Li J
Mol Med Rep; 2018 Mar; 17(3):4291-4298. PubMed ID: 29328472
[TBL] [Abstract][Full Text] [Related]
23. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma.
Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J
Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125
[TBL] [Abstract][Full Text] [Related]
24. MiR-125b inhibits cell biological progression of Ewing's sarcoma by suppressing the PI3K/Akt signalling pathway.
Li J; You T; Jing J
Cell Prolif; 2014 Apr; 47(2):152-60. PubMed ID: 24517182
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of EWSR1 (Ewing sarcoma breakpoint region 1/EWS RNA binding protein 1) predicts poor survival in patients with hepatocellular carcinoma.
Jiang W; Wu T; Shi X; Xu J
Bioengineered; 2021 Dec; 12(1):7941-7949. PubMed ID: 34612781
[TBL] [Abstract][Full Text] [Related]
26. Sialidase
Peng Q; Gao L; Cheng HB; Wang JS; Wang J
World J Oncol; 2022 Aug; 13(4):222-234. PubMed ID: 36128592
[TBL] [Abstract][Full Text] [Related]
27. COL3A1 and Its Related Molecules as Potential Biomarkers in the Development of Human Ewing's Sarcoma.
Tang M; Liu P; Wu X; Gong J; Weng J; Gao G; Liu Y; Gan L
Biomed Res Int; 2021; 2021():7453500. PubMed ID: 35047627
[TBL] [Abstract][Full Text] [Related]
28. Effects of sialidase NEU1 siRNA on proliferation, apoptosis, and invasion in human ovarian cancer.
Ren LR; Zhang LP; Huang SY; Zhu YF; Li WJ; Fang SY; Shen L; Gao YL
Mol Cell Biochem; 2016 Jan; 411(1-2):213-9. PubMed ID: 26463994
[TBL] [Abstract][Full Text] [Related]
29. Sialidase NEU1 suppresses progression of human bladder cancer cells by inhibiting fibronectin-integrin α5β1 interaction and Akt signaling pathway.
Zhou X; Zhai Y; Liu C; Yang G; Guo J; Li G; Sun C; Qi X; Li X; Guan F
Cell Commun Signal; 2020 Mar; 18(1):44. PubMed ID: 32164705
[TBL] [Abstract][Full Text] [Related]
30. CCT6A, a novel prognostic biomarker for Ewing sarcoma.
Jiang J; Liu C; Xu G; Liang T; Yu C; Liao S; Zhang Z; Lu Z; Wang Z; Chen J; Chen T; Li H; Zhan X
Medicine (Baltimore); 2021 Jan; 100(4):e24484. PubMed ID: 33530265
[TBL] [Abstract][Full Text] [Related]
31. Downregulation of GNA15 Inhibits Cell Proliferation
Li M; Liu Y; Liu Y; Yang L; Xu Y; Wang W; Jiang Z; Liu Y; Wang S; Wang C
Front Oncol; 2021; 11():724435. PubMed ID: 34552875
[TBL] [Abstract][Full Text] [Related]
32. BIRC5 expression is a poor prognostic marker in Ewing sarcoma.
Hingorani P; Dickman P; Garcia-Filion P; White-Collins A; Kolb EA; Azorsa DO
Pediatr Blood Cancer; 2013 Jan; 60(1):35-40. PubMed ID: 22961763
[TBL] [Abstract][Full Text] [Related]
33. Identification of key genes and pathways in Ewing's sarcoma using bioinformatics analysis.
Yan C; Wang Y; Wang Q; Feng X; Wang L; Bu Z; Lu B; Jiang J
J BUON; 2018; 23(5):1472-1480. PubMed ID: 30570875
[TBL] [Abstract][Full Text] [Related]
34. [Effect and mechanism of circular RNA BICD2 on the biological behavior of oral squamous cell carcinoma cells].
Zhang YJ; Zhu QQ; Zhou HX; Wang HY; Zhou H
Zhonghua Kou Qiang Yi Xue Za Zhi; 2021 Nov; 56(11):1098-1108. PubMed ID: 34763405
[No Abstract] [Full Text] [Related]
35. Prognostic value of PRR11 and immune cell infiltration in Ewing sarcoma.
Wen J; Wan L; Dong X
PLoS One; 2024; 19(3):e0299720. PubMed ID: 38427643
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive analysis of multi Ewing sarcoma microarray datasets identifies several prognosis biomarkers.
Yin X; Sun J; Zhang H; Wang S
Mol Med Rep; 2018 Nov; 18(5):4229-4238. PubMed ID: 30221671
[TBL] [Abstract][Full Text] [Related]
37. KIF4A enhanced cell proliferation and migration via Hippo signaling and predicted a poor prognosis in esophageal squamous cell carcinoma.
Sun X; Chen P; Chen X; Yang W; Chen X; Zhou W; Huang D; Cheng Y
Thorac Cancer; 2021 Feb; 12(4):512-524. PubMed ID: 33350074
[TBL] [Abstract][Full Text] [Related]
38. [LncRNA DRAIC regulates the proliferation, apoptosis, migration and invasion of lung adenocarcinoma cells by targeting let-7i-5p].
Liu BL; Cui YS; Tian YP; Zhu YZ; Hong ZQ; Zhang XM; Sun GG
Zhonghua Zhong Liu Za Zhi; 2023 Jun; 45(6):471-481. PubMed ID: 37355465
[No Abstract] [Full Text] [Related]
39. EphA2 receptor is a key player in the metastatic onset of Ewing sarcoma.
Garcia-Monclús S; López-Alemany R; Almacellas-Rabaiget O; Herrero-Martín D; Huertas-Martinez J; Lagares-Tena L; Alba-Pavón P; Hontecillas-Prieto L; Mora J; de Álava E; Rello-Varona S; Giangrande PH; Tirado OM
Int J Cancer; 2018 Sep; 143(5):1188-1201. PubMed ID: 29582409
[TBL] [Abstract][Full Text] [Related]
40. Combining PARP-1 inhibition and radiation in Ewing sarcoma results in lethal DNA damage.
Lee HJ; Yoon C; Schmidt B; Park DJ; Zhang AY; Erkizan HV; Toretsky JA; Kirsch DG; Yoon SS
Mol Cancer Ther; 2013 Nov; 12(11):2591-600. PubMed ID: 23966622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
